Mayla Competitors

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artificial intelligence benefits all of humanity. AI is an extremely powerful tool that must be created with safety and human needs at its core. OpenAI is dedicated to putting that alignment of interests first — ahead of profit. To achieve our mission, we must encompass and value the many different perspectives, voices, and experiences that form the full spectrum of humanity. Our investment in diversity, equity, and inclusion is ongoing, executed through a wide range of initiatives, and championed and supported by leadership. At OpenAI, we believe artificial intelligence has the potential to help people solve immense global challenges, and we want the upside of AI to be widely shared. Join us in shaping the future of technology.

Synthesia is the world’s leading AI video platform for business, trusted by over 90% of the Fortune 100, including Amazon, Zoom, Microsoft, and more. As AI continues to shape the way we live and work, Synthesia develops products to enhance visual communication and enterprise skill development, helping people work better and stay at the center of successful organizations.

The ZETA Group is an end-to-end solution provider operating globally and specializing in the design, construction, automation, digitization and qualification of customer-specific biopharmaceutical systems for aseptic process solutions. ZETA provides support after commissioning of the process equipment through targeted ramp-up as well as service and maintenance along the entire product lifecyle. True to the principle of continuous improvement, ZETA guides customers during process and system optimization as well as operator training. As general planners (EPCM), ZETA manages major, high-complexity pharma projects and specifically reduces interfaces—from the planning and construction of the process system through the cleanroom design up to the technical building infrastructure. This design-build approach accelerates the project execution time by up to 50% and leads to creation of value earlier in the customer’s capex projects. In the field of digitization, ZETA’s fully integrated digital value chain—from engineering through qualification and operator management—has established the company as an innovation driver in the pharma and biotech industry. ZETA is also actively taking steps towards a more sustainable future for the entire industry: By holistic decarbonization strategies that reduce targeted emissions during the biopharmaceutical manufacturing process. Your reliable partner for biopharmaceutical projects: • EPCMv contractor • Plant engineering • HVAC-, cleanroom and BMS/EMS design • Decarbonization • Automation • Digitalisation • Qualification • Maintenance & Upgrades • Research & Development Legal Notice: https://www.zeta.com/legal-notice/ Data Protection: https://www.zeta.com/data-protection/